Guardian Pharmacy ServicesGRDN -0.24%42 ROA % is 12.67% as of Mar. 2026, which is 36% above its 10-year median of 9.35. GuruFocus rates GRDN with a GF Score™ of 42/100. The stock has 4 warning signs investors should review. Among 682 Healthcare Providers & Services companies, Guardian Pharmacy Services ranks better than 93.11% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Guardian Pharmacy Services's annualizedNet Income for the quarter that ended in Mar. 2026 was $53 Mil.
Guardian Pharmacy Services's average Total Assets over the quarter that ended in Mar. 2026 was $420 Mil. Therefore, Guardian Pharmacy Services's annualized ROA % for the quarter that ended in Mar. 2026 was 12.67%.
The historical rank and industry rank for Guardian Pharmacy Services's ROA % or its related term are showing as below:
GRDN'
s ROA % Range Over the Past 10 Years
Min: -29.49 Med: 9.35 Max: 14.4
Current: 13.82
During the past 8 years, Guardian Pharmacy Services's highest ROA % was 14.40%. The lowest was -29.49%. And the median was 9.35%.
GRDN's ROA % is ranked better than 93.11% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 1.8
vs GRDN: 13.82
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Guardian Pharmacy Services's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guardian Pharmacy Services ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Guardian Pharmacy Services's ROA % distribution charts can be found below:
* The bar in red indicates where Guardian Pharmacy Services's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Guardian Pharmacy Services (GRDN) has a ROA % of 12.67% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Guardian Pharmacy Services and its competitors. This is 36% above median its historical median of 9.35. According to the industry distribution chart, Guardian Pharmacy Services ranks #47 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 6.9%.
Is Guardian Pharmacy Services' ROA % too high?
Guardian Pharmacy Services' current ROA % of 12.67% is 36% above median its 10-year median of 9.35. The Healthcare Providers & Services industry median ROA % is 1.80. Guardian Pharmacy Services' value of 12.67% is 603.9% above this industry median. Based on the distribution chart, Guardian Pharmacy Services ranks #47 out of 682 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Guardian Pharmacy Services has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Guardian Pharmacy Services' ROA % compare to ACHC and ASTH?
According to the Healthcare Providers & Services industry distribution chart, Guardian Pharmacy Services ranks #47 out of 682 companies for ROA %. This places Guardian Pharmacy Services in the top 7% of its industry — outperforming the majority of peers. The industry median ROA % is 1.80. Guardian Pharmacy Services' value of 12.67% is 603.9% above this benchmark. While the company's 10-year median is 9.35 vs. the industry median of 1.80, Guardian Pharmacy Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.80, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guardian Pharmacy Services's current ROA % of 12.67% is 603.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Guardian Pharmacy Services and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guardian Pharmacy Services's current ROA % is 12.67%, which is 36% above median its own 10-year median of 9.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardian Pharmacy Services stock overvalued right now?
Guardian Pharmacy Services (GRDN) has a current ROA % of 12.67%. The current ROA % is 12.67%, which is 36% above median its 10-year median of 9.35 and 603.9% above the Healthcare Providers & Services industry median of 1.80. Guardian Pharmacy Services' overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Guardian Pharmacy Services (GRDN), the current ROA % is 12.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
42GF Score
Get the complete analysis for GRDN
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRDN has been successfully added to your 
